We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has approved a new label for Novartis’ wet age-related macular degeneration (AMD) treatment Beovu (brolucizumab) with added safety information. Read More
Attorneys general from all 50 states have filed a lawsuit against dozens of generic drugmakers alleging price fixing for more than 80 topical drugs. Read More
Fujifilm said it plans to invest $928 million to double production capacity at its biologics manufacturing facility in Denmark to supply bulk drug substances for future COVID-19 therapies and other products. Read More
Pfizer’s chairman and CEO Albert Bourla promised on Tuesday that the company will set an ethical price for its COVID-19 vaccine if it gains approval. Read More
AbbVie has prevailed in a lawsuit alleging that it violated antitrust laws by exploiting the patent system and making deals with companies for its blockbuster drug Humira (adalimumab). Read More
Researchers funded by the National Institutes of Health (NIH) are evaluating drugs doctors are using to treat COVID-19 in infants, children and adolescents. Read More
Partly in response to the COVID-19 pandemic, HHS is partnering with a Boston-based drugmaker to create a domestic supply chain that doesn’t rely on foreign sources for active pharmaceutical ingredients. Read More